MEDIWOUND LTD. (MDWD)

Director Rubinstein Samuel 🟡 adjusted position in 26.6K shares (4 derivative) of MediWound Ltd. (MDWD) at $18.54 Transaction Date: Sep 01, 2026 | Filing ID: 004392

Register to leave comments

  • News bot Sept. 2, 2026, 8:04 p.m.

    🔍 Rubinstein Samuel (Director)

    Company: MediWound Ltd. (MDWD)

    Report Date: 2026-09-01

    Transaction Summary:

    • Total transactions: 8
    • Derivative instruments: 4
    • Holdings reported: 6
    • Total shares acquired: 525
    • Total shares sold: 525
    • Total shares held: 30,335

    Detailed Transactions and Holdings:

    • Sold 525 shares of Ordinary Shares at $12.72 per share (Direct)
      Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4
    • Acquired 525 shares of Ordinary Shares at $12.62 per share (Direct)
      Date: 2026-09-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 525.00 | transaction_form_type: 4
    • Holds 0 shares of Ordinary Shares (Direct)
      Date: 2026-09-01 | Code: H | shares_owned_after: 2,993.00 | Footnotes: F2
    • Holds 0 shares of Ordinary shares (Direct)
      Date: 2026-09-01 | Code: H | shares_owned_after: 750.00 | Footnotes: F1
    • Holds 7,200 shares of Stock Option (right to buy ordinary shares) at $9.64 per share (Derivative)
      Date: 2026-09-01 | Code: H | Expires: 2033-08-15 | Exercise: 2024-08-15 | shares_owned_after: 7,200.00 | Footnotes: F2
    • Holds 7,542 shares of Stock Option (right to buy ordinary shares) at $12.729 per share (Derivative)
      Date: 2026-09-01 | Code: H | Expires: 2034-02-26 | Exercise: 2025-02-26 | shares_owned_after: 7,542.00 | Footnotes: F2
    • Holds 5,600 shares of Stock Option (right to buy ordinary shares) at $18.54 per share (Derivative)
      Date: 2026-09-01 | Code: H | Expires: 2035-02-11 | Exercise: 2026-02-11 | shares_owned_after: 5,600.00 | Footnotes: F2
    • Holds 6,250 shares of Stock Option (right to buy ordinary shares) at $17.6 per share (Derivative)
      Date: 2026-09-01 | Code: H | Expires: 2036-03-04 | shares_owned_after: 6,250.00 | Footnotes: F2, F3

    Footnotes:

    • F1: The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
    • F2: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
    • F3: The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
    • REMARKS: The Issuer is a foreign private issuer as defined under Rule 3b-4 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). In accordance with Rule 3a12-3(b) under the Exchange Act, the Reporting Person is exempt from the short-swing profit recovery provisions of Section 16(b) of the Exchange Act.